Literature DB >> 25465345

Using qualitative data, people's perceptions, and the science of decision making to inform policy and improve hepatitis C care for people who use drugs.

David C Perlman1, Ashly E Jordan2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25465345      PMCID： PMC4445640          DOI： 10.1016/j.drugpo.2014.10.006

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN： 0955-3959


× No keyword cloud information.
  20 in total

1.  Shared decision making--pinnacle of patient-centered care.

Authors:  Michael J Barry; Susan Edgman-Levitan
Journal:  N Engl J Med       Date:  2012-03-01       Impact factor: 91.245

2.  Prevention of hepatitis C virus in injecting drug users: a narrow window of opportunity.

Authors:  Jason Grebely; Gregory J Dore
Journal:  J Infect Dis       Date:  2011-01-31       Impact factor: 5.226

3.  Role of social network dimensions in the transition to injection drug use: actions speak louder than words.

Authors:  Nana Koram; Hongjie Liu; Jianhua Li; Jian Li; Jian Luo; Jennifer Nield
Journal:  AIDS Behav       Date:  2011-10

4.  Perceptions of genetic testing and genomic medicine among drug users.

Authors:  David C Perlman; Camila Gelpí-Acosta; Samuel R Friedman; Ashly E Jordan; Holly Hagan
Journal:  Int J Drug Policy       Date:  2014-06-24

Review 5.  Global estimates of prevalence of HCV infection among injecting drug users.

Authors:  Carmen Aceijas; Tim Rhodes
Journal:  Int J Drug Policy       Date:  2007-08-07

6.  Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S.

Authors:  Corrine E Munoz-Plaza; Shiela Strauss; Janetta Astone-Twerell; Don Des Jarlais; Marya Gwadz; Holly Hagan; Andrew Osborne; Andrew Rosenblum
Journal:  Int J Drug Policy       Date:  2007-08-06

Review 7.  The epidemiology of chronic hepatitis C and one-time hepatitis C virus testing of persons born during 1945 to 1965 in the United States.

Authors:  John W Ward
Journal:  Clin Liver Dis       Date:  2013-02       Impact factor: 6.126

8.  Epidemiological aspects of HCV infection in non-injecting drug users in the Brazilian state of Pará, eastern Amazon.

Authors:  Aldemir B Oliveira-Filho; Leila Sawada; Laine C Pinto; Daiane Locks; Santana L Bahia; Jairo A A Castro; Renata B Hermes; Igor Brasil-Costa; Carlos E M Amaral; José Alexandre R Lemos
Journal:  Virol J       Date:  2014-02-25       Impact factor: 4.099

Review 9.  Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention.

Authors:  Lucas Wiessing; Marica Ferri; Bart Grady; Maria Kantzanou; Ida Sperle; Katelyn J Cullen; Angelos Hatzakis; Maria Prins; Peter Vickerman; Jeffrey V Lazarus; Vivian D Hope; Catharina Matheï
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

10.  Perceptions of drug users regarding hepatitis C screening and care: a qualitative study.

Authors:  Ashly E Jordan; Carmen L Masson; Pedro Mateu-Gelabert; Courtney McKnight; Nicole Pepper; Katie Bouche; Laura Guzman; Evan Kletter; Randy M Seewald; Don C Des-Jarlais; James L Sorensen; David C Perlman
Journal:  Harm Reduct J       Date:  2013-06-20
View more
  3 in total

1.  An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.

Authors:  David C Perlman; Ashly E Jordan; Anneli Uuskula; Duong Thi Huong; Carmen L Masson; Bruce R Schackman; Don C Des Jarlais
Journal:  Int J Drug Policy       Date:  2015-04-27

Review 2.  Conceptualizing Care Continua: Lessons from HIV, Hepatitis C Virus, Tuberculosis and Implications for the Development of Improved Care and Prevention Continua.

Authors:  David C Perlman; Ashly E Jordan; Denis Nash
Journal:  Front Public Health       Date:  2017-01-10

3.  Patterns and Gaps Identified in a Systematic Review of the Hepatitis C Virus Care Continuum in Studies among People Who Use Drugs.

Authors:  Ashly E Jordan; David C Perlman; Jennifer Reed; Daniel J Smith; Holly Hagan
Journal:  Front Public Health       Date:  2017-12-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.